Residual mass after chemotherapy for seminoma: Changing concepts of management Journal Article

  


Authors: Herr, H. W.; Bosl, G.
Article Title: Residual mass after chemotherapy for seminoma: Changing concepts of management
Abstract: A residual mass after induction chemotherapy for advanced seminoma may present radiographically and clinically as either retroperitoneal fibrosis or a discrete mass. The former is nonresectable and often it is associated with negative pathological findings, whereas the latter is resectable but frequently it consists of viable seminoma, providing an indication for further therapy.
Keywords: case report; doxorubicin; cancer combination chemotherapy; drug efficacy; chemotherapy; vinblastine; diagnosis; bleomycin; radiography; management; seminoma; therapy; intravenous drug administration; male genital system; human; priority journal
Journal Title: Journal of Urology
Volume: 137
Issue: 6
ISSN: 0022-5347
Publisher: Elsevier Science, Inc.  
Date Published: 1987-06-01
Start Page: 1234
End Page: 1235
Language: English
DOI: 10.1016/s0022-5347(17)44465-x
PUBMED: 2438431
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023198254&doi=10.1016%2fS0022-5347%2817%2944465-X&partnerID=40&md5=333a84cacecc7c6f97bc1878b717d290
Notes: Article -- Export Date: 5 February 2021 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Harry W Herr
    594 Herr
  2. George Bosl
    430 Bosl
Related MSK Work